Nathan Perlis, MSc, MD, FRCSC

Follow Dr. Perlis:

Dr. Nathan Perlis is a Staff Urologist in the Department of Surgical Oncology at the Princess Margaret Cancer Centre and an Assistant Professor in the Department of Surgery at the University of Toronto. Dr. Perlis received his B.A. from Tufts University in 2002 and his M.D. from the University of Toronto in 2008. From 2008-2015, he completed his Urology Residency and his Masters of Science in Clinical Epidemiology at the University of Toronto’s Institute of Health Policy, Management & Evaluation. Following residency, Dr. Perlis completed his urologic oncology fellowship through the Society of Urological Oncology at the University of Toronto.

Dr. Perlis is interested in understanding the patient experience through studying patient preferences, decision making, and quality of life. He is the recipient of the Early Investigator Research Scholarship Grant awarded by the Canadian Urological Association Scholarship Foundation (CUASF) to create patient-centred prostate magnetic resonance imaging (MRI) reports.

Ongoing Research Projects: 
  • Patient preferences, decision making, experience and quality of life in bladder cancer
  • Clinical outcomes, prediction and modelling for prostate cancer
  • Novel therapeutics and technology for treatment of localized prostate cancer including photodynamic therapy, high-intensity focused ultrasound (HIFU), and laser photothermal therapy
  • Clinical trials using Focal Therapy (partial gland ablation) in prostate cancer


J Urol. 2019 Oct 14;:101097JU0000000000000595
Goldberg H, Ahmad AE, Chandrasekar T, Klotz L, Emberton M, Haider MA, Taneja SS, Arora K, Fleshner N, Finelli A, Perlis N, Tyson MD, Klaassen Z, Wallis CJD
Can Urol Assoc J. 2019 Aug;13(8):250-255
Tan GH, Finelli A, Ahmad A, Wettstein MS, Chandrasekar T, Zlotta AR, Fleshner NE, Hamilton RJ, Kulkarni GS, Ajib K, Nason G, Perlis N
Eur Urol Focus. 2019 May 03;:
Perlis N, Ghai S, Tan GH, Finelli A
Eur Urol Oncol. 2019 Feb;2(1):88-96
Goldberg H, Ramiz AH, Glicksman R, Salgado NS, Chandrasekar T, Klaassen Z, Wallis CJD, Hosni A, Moraes FY, Ghai S, Kulkarni GS, Hamilton RJ, Perlis N, Toi A, Chung P, Evans A, van der Kwast T, Finelli A, Fleshner N, Berlin A
World J Urol. 2019 Mar 11;:
Tan GH, Nason G, Ajib K, Woon DTS, Herrera-Caceres J, Alhunaidi O, Perlis N
Urol Oncol. 2019 Feb 13;:
Sayyid RK, Alibhai SMH, Sutradhar R, Eberg M, Fung K, Klaassen Z, Goldberg H, Perlis N, Madi R, Terris MK, Urbach DR, Fleshner NE
J Urol. 2019 02;201(2):320-321
Perlis N
J Urol. 2019 01;201(1):82
Perlis N
J Urol. 2018 Nov;200(5):1056-1061
Goldberg H, Klaassen Z, Chandrasekar T, Wallis CJD, Toi A, Sayyid R, Bhindi B, Nesbitt M, Evans A, van der Kwast T, Sweet J, Perlis N, Hamilton RJ, Kulkarni GS, Finelli A, Zlotta A, Fleshner N
Eur Radiol. 2018 Oct;28(10):4281-4287
Ghai S, Perlis N, Lindner U, Hlasny E, Haider MA, Finelli A, Zlotta AR, Kulkarni GS, van der Kwast TH, McCluskey SA, Kucharczyk W, Trachtenberg J


Staff Urologist, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network
Assistant Professor, Department of Surgery, University of Toronto